Walgreens Boots Alliance Inc

Walgreens Boots Alliance — Non-Deal Roadshow (November 2015)

28 slides from Walgreens Boots Alliance's roadshow presentation, Nov 2, 2015

  1. Slide 1: Investor Roadshow materials November 2015

    Slide 1: Investor Roadshow materials November 2015

    Walgreens Boots Alliance Investor Roadshow materials November 2015 Exhibit 99.1

  2. Slide 2: Safe Harbor and Non-GAAP

    Slide 2: Safe Harbor and Non-GAAP

    Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on our current market, competitive and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. Except to

  3. Slide 3: Agreement to acquire Rite Aid

    Slide 3: Agreement to acquire Rite Aid

    Walgreens Boots Alliance Agreement to acquire Rite Aid IR Roadshow - November 2015

  4. Slide 4: Transaction rationale: Agreement to acquire Rite Aid

    Slide 4: Transaction rationale: Agreement to acquire Rite Aid

    † Forward-Looking Statements – see cautionary note in attached Appendix. Economies of scale create efficiencies and cost savings Provides opportunity to develop the Rite Aid retail product offering Shift to improve category mix Expand distribution of exclusive global beauty brands including No.7, So

  5. Slide 5: Transaction rationale: expands footprint and fills coverage gaps

    Slide 5: Transaction rationale: expands footprint and fills coverage gaps

    † Forward-Looking Statements – see cautionary note in attached Appendix. Transaction rationale Agreement to acquire Rite Aid† Expands store footprint and fills coverage gaps Expanding distribution of exclusive global beauty brands including No.7, Soap & Glory, Botanics and Liz Earle Improves WBA ret

  6. Slide 6: Agreement to acquire Rite Aid: Transaction overview

    Slide 6: Agreement to acquire Rite Aid: Transaction overview

    Agreement to acquire Rite Aid† † Forward-Looking Statements – see cautionary note in attached Appendix. Transaction overview $9.00 per share in cash, total enterprise value of $17.2 billion Subject to approval by Rite Aid shareholders, regulatory clearances and other customary closing conditions Con

  7. Slide 7: Full Year 2015 / 4th Quarter 2015 Earnings

    Slide 7: Full Year 2015 / 4th Quarter 2015 Earnings

    IR Roadshow - November 2015 Walgreens Boots Alliance Full Year 2015 / 4th Quarter 2015 Earnings

  8. Slide 8: Walgreens Boots Alliance consolidated results – FY15

    Slide 8: Walgreens Boots Alliance consolidated results – FY15

    $ in millions (except diluted and adjusted diluted EPS) Walgreens Boots Alliance consolidated results – FY15 1. Net Earnings and Earnings per share figures are attributable to Walgreens Boots Alliance, Inc. 2. All periods presented adjusted for: acquisition-related amortization, LIFO provision, Alli

  9. Slide 9: Walgreens Boots Alliance consolidated results – 4Q15

    Slide 9: Walgreens Boots Alliance consolidated results – 4Q15

    $ in millions (except diluted and adjusted diluted EPS) Walgreens Boots Alliance consolidated results – 4Q15 GAAP 4Q15 4Q14 Net Sales $28,522 $19,057 Operating Income $836 $986 Interest Expense, net $255 $43 Net Earnings1 $26 ($221) Diluted EPS1 $0.02 ($0.23) Non-GAAP3 4Q152 4Q142 Adjusted Operating

  10. Slide 10: Cash flows and capital deployment

    Slide 10: Cash flows and capital deployment

    Cash flows and capital deployment 1. Non-GAAP financial measures– see attached Appendix. 2. Under the August 2014 $3 billion authorization for repurchases through the end of fiscal year 2016. Cash Flow FY15 4Q15 GAAP Operating Cash Flow $5.7 billion $1.5 billion Key financing activities Free Cash Fl

  11. Slide 11: Outlook

    Slide 11: Outlook

    IR Roadshow - November 2015 Walgreens Boots Alliance Outlook

  12. Slide 12: Outlook: Fiscal year 2016 guidance

    Slide 12: Outlook: Fiscal year 2016 guidance

    Outlook: Fiscal year 2016 guidance† 1. Non-GAAP financial measure – see attached Appendix. † Forward-Looking Statements – see cautionary note in attached Appendix. Metric Guidance† Adjusted EPS1 $4.25 - $4.55 Factors in suspension of activity under $3.0 billion share buyback program Expectation of g

  13. Slide 13: Well Positioned for the Future

    Slide 13: Well Positioned for the Future

    Well Positioned for the Future

  14. Slide 14: Non-GAAP financial measures reconciliations

    Slide 14: Non-GAAP financial measures reconciliations

    The following information provides reconciliations of the supplemental non-GAAP financial measures, as defined under SEC rules, presented in this presentation to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles in th

  15. Slide 15: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Slide 15: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

  16. Slide 16: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Slide 16: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

  17. Slide 17: Reconciliation of Non-GAAP financial measures

    Slide 17: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  18. Slide 18: Reconciliation of Non-GAAP financial measures

    Slide 18: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  19. Slide 19: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Slide 19: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.

    Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

  20. Slide 20: Reconciliation of Non-GAAP financial measures

    Slide 20: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  21. Slide 21: Reconciliation of Non-GAAP financial measures

    Slide 21: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  22. Slide 22: Reconciliation of Non-GAAP financial measures

    Slide 22: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  23. Slide 23: Reconciliation of Non-GAAP financial measures

    Slide 23: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  24. Slide 24: Reconciliation of Non-GAAP financial measures

    Slide 24: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  25. Slide 25: Reconciliation of Non-GAAP financial measures

    Slide 25: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures

  26. Slide 26: Free cash flow definition

    Slide 26: Free cash flow definition

    1. Free cash flow is defined as net cash provided by operating activities in a period minus additions to property, plant and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not dedu

  27. Slide 27: Certain definitions and assumptions

    Slide 27: Certain definitions and assumptions

    Certain definitions and assumptions Certain Assumptions: Unless the context otherwise indicates or requires: This presentation assumes constant currency exchange rates after the date hereof based on current rates; All financial estimates and goals assume constant currency exchange rates after the da

  28. Slide 28: Cautionary note regarding forward-looking statements

    Slide 28: Cautionary note regarding forward-looking statements

    Cautionary note regarding forward-looking statements Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not historical including, without limitation, estimates of and goals for future financial and operating performance, the

Source: SEC EDGAR · 8-K filed Nov 2, 2015

More decks from Walgreens Boots Alliance Inc